Ethos Financial Group LLC Acquires Shares of 906 Cigna Group $CI

Ethos Financial Group LLC bought a new stake in shares of Cigna Group (NYSE:CI) during the 2nd quarter, according to its most recent filing with the SEC. The firm bought 906 shares of the health services provider’s stock, valued at approximately $300,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Retirement Systems of Alabama grew its holdings in Cigna Group by 3.9% during the 2nd quarter. Retirement Systems of Alabama now owns 165,487 shares of the health services provider’s stock worth $54,707,000 after acquiring an additional 6,155 shares in the last quarter. Modern Wealth Management LLC lifted its position in shares of Cigna Group by 91.3% during the first quarter. Modern Wealth Management LLC now owns 3,130 shares of the health services provider’s stock worth $1,030,000 after purchasing an additional 1,494 shares during the last quarter. Janney Montgomery Scott LLC grew its stake in Cigna Group by 3.9% in the second quarter. Janney Montgomery Scott LLC now owns 35,943 shares of the health services provider’s stock worth $11,882,000 after purchasing an additional 1,357 shares in the last quarter. Acadian Asset Management LLC increased its holdings in Cigna Group by 277.5% in the first quarter. Acadian Asset Management LLC now owns 8,274 shares of the health services provider’s stock valued at $2,718,000 after buying an additional 6,082 shares during the last quarter. Finally, Dynamic Technology Lab Private Ltd acquired a new stake in Cigna Group during the first quarter valued at approximately $431,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Analysts Set New Price Targets

CI has been the subject of a number of research analyst reports. JPMorgan Chase & Co. lowered their price target on Cigna Group from $428.00 to $375.00 and set an “overweight” rating for the company in a report on Tuesday. Deutsche Bank Aktiengesellschaft set a $415.00 price objective on shares of Cigna Group and gave the stock a “buy” rating in a report on Tuesday, August 5th. Barclays dropped their target price on shares of Cigna Group from $383.00 to $300.00 and set an “overweight” rating on the stock in a report on Friday, October 31st. Morgan Stanley reaffirmed an “overweight” rating and issued a $355.00 price target on shares of Cigna Group in a report on Friday, October 31st. Finally, Robert W. Baird set a $372.00 price objective on shares of Cigna Group in a research report on Thursday, August 14th. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating, three have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $344.91.

Insider Buying and Selling at Cigna Group

In related news, CEO David Cordani bought 4,134 shares of the firm’s stock in a transaction that occurred on Monday, November 3rd. The shares were acquired at an average cost of $241.88 per share, for a total transaction of $999,931.92. Following the acquisition, the chief executive officer directly owned 157,935 shares of the company’s stock, valued at $38,201,317.80. The trade was a 2.69% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, insider Nicole S. Jones sold 28,526 shares of the company’s stock in a transaction on Friday, August 15th. The shares were sold at an average price of $300.00, for a total value of $8,557,800.00. Following the sale, the insider directly owned 25,648 shares of the company’s stock, valued at approximately $7,694,400. This represents a 52.66% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.70% of the stock is owned by corporate insiders.

Cigna Group Price Performance

Shares of Cigna Group stock opened at $264.54 on Friday. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.65. The company’s 50-day moving average price is $293.24 and its two-hundred day moving average price is $303.77. Cigna Group has a 52 week low of $239.51 and a 52 week high of $350.00. The stock has a market cap of $70.66 billion, a PE ratio of 14.44, a price-to-earnings-growth ratio of 0.88 and a beta of 0.44.

Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, October 30th. The health services provider reported $7.83 earnings per share for the quarter, beating the consensus estimate of $7.64 by $0.19. The company had revenue of $69.57 billion during the quarter, compared to analyst estimates of $66.40 billion. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The business’s revenue for the quarter was up 9.5% on a year-over-year basis. During the same quarter last year, the firm posted $7.51 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, sell-side analysts anticipate that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, December 18th. Shareholders of record on Thursday, December 4th will be given a $1.51 dividend. The ex-dividend date is Thursday, December 4th. This represents a $6.04 annualized dividend and a yield of 2.3%. Cigna Group’s payout ratio is 26.64%.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.